These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 15150209)

  • 1. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
    Dalakas MC
    JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile.
    Dalakas MC
    Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases].
    Molnár MJ
    Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: present status and practical therapeutic guidelines.
    Dalakas MC
    Muscle Nerve; 1999 Nov; 22(11):1479-97. PubMed ID: 10514226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immune globulin therapy for neurologic diseases.
    Dalakas MC
    Ann Intern Med; 1997 May; 126(9):721-30. PubMed ID: 9139559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee.
    Tavee J; Brannagan TH; Lenihan MW; Muppidi S; Kellermeyer L; D Donofrio P;
    Muscle Nerve; 2023 Oct; 68(4):356-374. PubMed ID: 37432872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review.
    Fergusson D; Hutton B; Sharma M; Tinmouth A; Wilson K; Cameron DW; Hebert PC
    Transfusion; 2005 Oct; 45(10):1640-57. PubMed ID: 16181216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin.
    Soueidan SA; Dalakas MC
    Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Patwa HS; Chaudhry V; Katzberg H; Rae-Grant AD; So YT
    Neurology; 2012 Mar; 78(13):1009-15. PubMed ID: 22454268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
    Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
    Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intravenous IgG for treatment of neuromuscular diseases].
    Vedeler CA; Mellgren SI; Omdal R; Torbergsen T; Aasly J
    Tidsskr Nor Laegeforen; 2010 Sep; 130(17):1717-20. PubMed ID: 20835282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin use for neurologic diseases.
    Koski CL; Patterson JV
    J Infus Nurs; 2006; 29(3 Suppl):S21-8. PubMed ID: 16878852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology?
    Elovaara I; Hietaharju A
    Acta Neurol Scand; 2010 Nov; 122(5):309-15. PubMed ID: 20085560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin for treatment of neuromuscular disease.
    Ruzhansky K; Brannagan TH
    Neurol Clin Pract; 2013 Oct; 3(5):440-445. PubMed ID: 29473612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidelines on the use of intravenous immune globulin for neurologic conditions.
    Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions report of the AANEM ad hoc committee.
    Donofrio PD; Berger A; Brannagan TH; Bromberg MB; Howard JF; Latov N; Quick A; Tandan R
    Muscle Nerve; 2009 Nov; 40(5):890-900. PubMed ID: 19768755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intravenous immunoglobulin and plasma exchange in neurological disease.
    Linker RA; Gold R
    Curr Opin Neurol; 2008 Jun; 21(3):358-65. PubMed ID: 18451723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
    Bembeeva RT; Zavadenko NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):83-93. PubMed ID: 26356621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.